The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia – FutureNeuro

Skip to content

Search our Website

Read about our first My Moving Brain Event

Home•Our Research•Publications•The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia

The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia

Thematic Area:

Therapeutics

Disease Area:

Epilepsy

Research Focus:

Drug Discovery Inflammation

Collaborators:

Academic